MedAdvisor explores hospital admission and discharge as revenue rises

Medications adherence software vendor MedAdvisor has reported a 110 per cent rise in revenue over the same time last year as it begins to build on the $9.5 million investment made by healthcare consumables and equipment provider EBOS Group last year.

The ASX-listed Melbourne firm says it now has 2665 enrolled pharmacies and almost one million patients using the platform, and plans to work in the coming year with EBOS subsidiary HPS on a product that may help reduce readmissions to hospital.